These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 35150013)

  • 1. Omicron BA.2 lineage spreads in clusters and is concentrated in Denmark.
    Desingu PA; Nagarajan K
    J Med Virol; 2022 Jun; 94(6):2360-2364. PubMed ID: 35150013
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular epidemiology of the SARS-CoV-2 variant Omicron BA.2 sub-lineage in Denmark, 29 November 2021 to 2 January 2022.
    Fonager J; Bennedbæk M; Bager P; Wohlfahrt J; Ellegaard KM; Ingham AC; Edslev SM; Stegger M; Sieber RN; Lassauniere R; Fomsgaard A; Lillebaek T; Svarrer CW; Møller FT; Møller CH; Legarth R; Sydenham TV; Steinke K; Paulsen SJ; Castruita JAS; Schneider UV; Schouw CH; Nielsen XC; Overvad M; Nielsen RT; Marvig RL; Pedersen MS; Nielsen L; Nilsson LL; Bybjerg-Grauholm J; Tarpgaard IH; Ebsen TS; Lam JUH; Gunalan V; Rasmussen M
    Euro Surveill; 2022 Mar; 27(10):. PubMed ID: 35272746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimating relative generation times and reproduction numbers of Omicron BA.1 and BA.2 with respect to Delta variant in Denmark.
    Ito K; Piantham C; Nishiura H
    Math Biosci Eng; 2022 Jun; 19(9):9005-9017. PubMed ID: 35942746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum Neutralization of SARS-CoV-2 Omicron BA.1 and BA.2 after BNT162b2 Booster Vaccination.
    Pedersen RM; Bang LL; Madsen LW; Sydenham TV; Johansen IS; Jensen TG; Justesen US; Andersen TE
    Emerg Infect Dis; 2022 Jun; 28(6):1274-1275. PubMed ID: 35356875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiological characterisation of the first 785 SARS-CoV-2 Omicron variant cases in Denmark, December 2021.
    Espenhain L; Funk T; Overvad M; Edslev SM; Fonager J; Ingham AC; Rasmussen M; Madsen SL; Espersen CH; Sieber RN; Stegger M; Gunalan V; Wilkowski B; Larsen NB; Legarth R; Cohen AS; Nielsen F; Lam JUH; Lavik KE; Karakis M; Spiess K; Marving E; Nielsen C; Wiid Svarrer C; Bybjerg-Grauholm J; Olsen SS; Jensen A; Krause TG; Müller L
    Euro Surveill; 2021 Dec; 26(50):. PubMed ID: 34915977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analyzing and Modeling the Spread of SARS-CoV-2 Omicron Lineages BA.1 and BA.2, France, September 2021-February 2022.
    Sofonea MT; Roquebert B; Foulongne V; Morquin D; Verdurme L; Trombert-Paolantoni S; Roussel M; Bonetti JC; Zerah J; Haim-Boukobza S; Alizon S
    Emerg Infect Dis; 2022 Jul; 28(7):1355-1365. PubMed ID: 35642476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Introduction and Rapid Spread of SARS-CoV-2 Omicron Variant and Dynamics of BA.1 and BA.1.1 Sublineages, Finland, December 2021.
    Vauhkonen H; Nguyen PT; Kant R; Plyusnin I; Erdin M; Kurkela S; Liimatainen H; Ikonen N; Blomqvist S; Liitsola K; Lindh E; Helve O; Jarva H; Loginov R; Palva A; Hannunen T; Hannula S; Parry M; Kauppi P; Vaheri A; Sironen T; Lappalainen M; Savolainen-Kopra C; Smura T; Vapalahti O
    Emerg Infect Dis; 2022 Jun; 28(6):1229-1232. PubMed ID: 35378057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection of Omicron sub-lineage infection against reinfection with another Omicron sub-lineage.
    Chemaitelly H; Ayoub HH; Coyle P; Tang P; Yassine HM; Al-Khatib HA; Smatti MK; Hasan MR; Al-Kanaani Z; Al-Kuwari E; Jeremijenko A; Kaleeckal AH; Latif AN; Shaik RM; Abdul-Rahim HF; Nasrallah GK; Al-Kuwari MG; Butt AA; Al-Romaihi HE; Al-Thani MH; Al-Khal A; Bertollini R; Abu-Raddad LJ
    Nat Commun; 2022 Aug; 13(1):4675. PubMed ID: 35945213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Convolutional Neural Networks Based on Sequential Spike Predict the High Human Adaptation of SARS-CoV-2 Omicron Variants.
    Nan BG; Zhang S; Li YC; Kang XP; Chen YH; Li L; Jiang T; Li J
    Viruses; 2022 May; 14(5):. PubMed ID: 35632811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenicity of SARS-CoV-2 Omicron (R346K) variant in Syrian hamsters and its cross-neutralization with different variants of concern.
    Mohandas S; Yadav PD; Sapkal G; Shete AM; Deshpande G; Nyayanit DA; Patil D; Kadam M; Kumar A; Mote C; Jain R
    EBioMedicine; 2022 May; 79():103997. PubMed ID: 35405385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 Omicron Variant, Lineage BA.1, Is Associated with Lower Viral Load in Nasopharyngeal Samples Compared to Delta Variant.
    Sentis C; Billaud G; Bal A; Frobert E; Bouscambert M; Destras G; Josset L; Lina B; Morfin F; Gaymard A; The Covid-Diagnosis Hcl Study Group
    Viruses; 2022 Apr; 14(5):. PubMed ID: 35632661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-neutralization of Omicron BA.1 against BA.2 and BA.3 SARS-CoV-2.
    Zou J; Kurhade C; Xia H; Liu M; Xie X; Ren P; Shi PY
    Nat Commun; 2022 May; 13(1):2956. PubMed ID: 35618703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Letter to the editor: Epidemiology of the SARS-CoV-2 variant Omicron BA.2 - vigilance needed.
    Huang J; Zeng G
    Euro Surveill; 2022 Mar; 27(13):. PubMed ID: 35362407
    [No Abstract]   [Full Text] [Related]  

  • 14. COVID-19 vaccine effectiveness against severe disease from SARS-CoV-2 Omicron BA.1 and BA.2 subvariants - surveillance results from southern Sweden, December 2021 to March 2022.
    Björk J; Bonander C; Moghaddassi M; Rasmussen M; Malmqvist U; Inghammar M; Kahn F
    Euro Surveill; 2022 May; 27(18):. PubMed ID: 35514304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tracking SARS-CoV-2 Omicron diverse spike gene mutations identifies multiple inter-variant recombination events.
    Ou J; Lan W; Wu X; Zhao T; Duan B; Yang P; Ren Y; Quan L; Zhao W; Seto D; Chodosh J; Luo Z; Wu J; Zhang Q
    Signal Transduct Target Ther; 2022 Apr; 7(1):138. PubMed ID: 35474215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic and epidemiological report of the recombinant XJ lineage SARS-CoV-2 variant, detected in northern Finland, January 2022.
    Lindh E; Smura T; Blomqvist S; Liitsola K; Vauhkonen H; Savolainen L; Ikonen J; Ronkainen J; Taskila J; Taskila T; Sakaranaho P; Savolainen-Kopra C; Vapalahti O; Ikonen N
    Euro Surveill; 2022 Apr; 27(16):. PubMed ID: 35451361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The significant immune escape of pseudotyped SARS-CoV-2 variant Omicron.
    Zhang L; Li Q; Liang Z; Li T; Liu S; Cui Q; Nie J; Wu Q; Qu X; Huang W; Wang Y
    Emerg Microbes Infect; 2022 Dec; 11(1):1-5. PubMed ID: 34890524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural Basis for Human Receptor Recognition by SARS-CoV-2 Omicron Variant BA.1.
    Geng Q; Shi K; Ye G; Zhang W; Aihara H; Li F
    J Virol; 2022 Apr; 96(8):e0024922. PubMed ID: 35343765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Omicron variant losing its critical mutations in the receptor-binding domain.
    Desingu PA; Nagarajan K
    J Med Virol; 2022 Jun; 94(6):2365-2368. PubMed ID: 35181921
    [No Abstract]   [Full Text] [Related]  

  • 20. Characteristics of the First 284 Patients Infected with the SARS-CoV-2 Omicron BA.2 Subvariant at a Single Center in the Apulia Region of Italy, January-March 2022.
    Loconsole D; Centrone F; Sallustio A; Accogli M; Casulli D; Sacco D; Zagaria R; Morcavallo C; Chironna M
    Vaccines (Basel); 2022 Apr; 10(5):. PubMed ID: 35632430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.